baber/WOPTO huggingface dataset:
Patent AU-713299-B2 (AU)
Title: Forward link carrier recovery in an OCDMA spread spectrum communication system without a pilot tone
Inventor: NATALI FRANCIS D
IPC: H04J11/00
Filed: 1997-03-24
Granted: 1999-11-25
Abstract: A spread spectrum CDMA communication system in which a base station communicates with a plurality of subscriber terminals and the base signal transmitted by the base station is comprised of a set of substantially orthogonal functions which are overlaid with a pseudo-noise (PN) sequence forming a coded spreading sequence for an information signal, each orthogonal function of the set carries data for a single user in the system. Information signals are modulated onto the carrier to form a transmit signal and the coded spreading sequence on the transmit signal for broadcasting, each subscriber terminal having a receiver for coherently demodulating the base station signal. A plurality of correlators, each respectively tuned to different functions of the orthogonal signal set, are each followed by an appropriate nonlinearity for removing the data modulation. The summed output of the correlators is used to improve the estimate of carrier phase over that obtained with a single correlator.
Patent AU-618071-B2 (AU)
Title: Penetrating treatment for porous substrates
Inventor: LARSON DONALD BRUCE
IPC: C04B41/48
Filed: 1989-02-09
Granted: 1991-12-12
Abstract: Improved durability and water repellency are provided to porous substrates by the use of a novel penetrating treatment composition comprising (A) C10 to C22 alkyl acrylate(s) or methacrylate(s) which are non-oxidizing and polymerizable to form homopolymers having a glass transition temperature of about 0 DEG C or less and (B) autoxidative compound(s) which function as polymerization initiator-oxygen scavenger, wherein the weight ratio of (A) to (B) is about 50 to 95 to about 50 to 5.
Patent AU-606274-B2 (AU)
Title: Rolled matrix device having enhanced ability to unroll and method for its production
Inventor: LO JEELIN
IPC: A61K9/22
Filed: 1989-03-20
Granted: 1991-01-31
Abstract: A method for enhancing the unrolling of an active agent-containing matrix device, including a laminate device, in an aqueous use environment, said device being constrained in a rolled configuration prior to placement in said environment, comprising coating one side of the device with an elastomer prior to constraining it in a rolled configuration; and the devices so treated.
Patent AU-672385-B2 (AU)
Title: Decontaminating and detoxifying method for domestic sanitation
Inventor: BLANC MICHEL
IPC: A61L2/22
Filed: 1993-02-05
Granted: 1996-10-03
Abstract: PCT No. PCT/FR93/00121 Sec. 371 Date Aug. 10, 1994 Sec. 102(e) Date Aug. 10, 1994 PCT Filed Feb. 5, 1993 PCT Pub. No. WO93/15774 PCT Pub. Date Aug. 19, 1993A process for decontamination and detoxification of a room wherein an atomizer is used to diffuse a product containing essential oils as a mist. The outer openings of the room to be decontaminated and detoxified are closed and the product is diffused as a true aerosol from the center of the room. After the diffusion is stopped, the mist is allowed to decontaminate and detoxify room and the room is then aired.
Patent AU-661762-B2 (AU)
Title: Method for producing carbohydrates
Inventor: YAN SAU-CHI BETTY
IPC: A61K45/00
Filed: 1993-03-11
Granted: 1995-08-03
Abstract: The invention relates to oligosaccharides with the sequence GalNAc beta (1-4) (Fuc alpha (1-3) GlcNAc. They are produced by incubating Human Kidney 293 cells and isolating the novel oligosaccharides from the peptide produced. oligosaccharides can be used to act as high affinity ligands of certain cell adhesion receptors, and may be used to prevent or reduce cell adhesion and inflammation.
Patent AU-570753-B2 (AU)
Title: Benzoxathiepin derivatives
Inventor: SUGIHARA HIROSADA
IPC: C07D411/06
Filed: 1984-12-10
Granted: 1988-03-24
Abstract: Novel 1,5-benzoxathiepin derivatives of the formula: <CHEM> [wherein R1 and R2 are independently hydrogen, halogen, hydroxy, lower alkyl or lower alkoxy; R3 and R4 are independently hydrogen, optionally substituted lower alkyl or optionally substituted cycloalkyl or optionally substituted aralkyl, or both jointly form an optionally substituted ring together with the adjacent nitrogen atom; X is hydrogen, optionally substituted lower alkyl, optionally substituted aryl or a carboxyl group which may be esterified or amidated; Y is  &rdurule& C=O or  &rdurule& CH-OR5 (wherein R5 is hydrogen, acyl or optionally substituted carbamoyl); m is an integer of 0 to 2; n is an integer of 1 to 6] and salts thereof exhibit serotonin S2 receptor blocking activity, calcium antagonism, actions to relieve cerebral vasospasm and to improve renal circulation and diuretic and antithrombotic activities, and are of value as a prophylactic and therapeutic agent for ischemic cardiopathies, thrombosis, hypertension and cerebral circulatory disorders.
Patent AU-678965-B2 (AU)
Title: Process for preparing low density porous crosslinked polymeric materials
Inventor: BESHOURI SHARON MARIE
IPC: C08F2/32
Filed: 1993-03-25
Granted: 1997-06-19
Abstract: The present disclosure is directed to using a blend of sorbitan esters as a surfactant to produce a stable water-in-oil high internal phase emulsion in the preparation of a low density porous crosslinked polymeric material. This process produces low density, high capacity, porous, crosslinked, polymeric materials with improved absorption capacity and foam properties.
Patent AU-669367-B2 (AU)
Title: Targeted cleavage of RNA using eukaryotic ribonuclease P and external guide sequence
Inventor: YUAN YAN
IPC: C12Q1/68
Filed: 1993-04-28
Granted: 1996-06-06
Abstract: It has been discovered that any RNA can be targeted for cleavage by RNAase P from eukaryotic cells, for example, human HeLa cells, using a suitably designed oligoribonucleotide ("external guide sequence", or EGS) to form a hybrid with the target RNA, thereby creating a substrate for cleavage by RNAase P in vitro. There are two classes of EGS that can target RNA for cleavage by human RNAase P. These are prepared by transcription from a small DNA fragment that contains a sequence coding for an RNA that can assume a tRNA-like secondary structure. In the first class, the structure lacks at least the first thirteen nucleotides from the 5' terminus of the tRNA-like sequence, the anticodon stem and loop, the variable loop or part of the variable loop. The most efficient EGS with human RNAase P is the EGS in which the anticodon stem and loop was deleted. In the second class, the EGS has changes in both the equivalent of the T-loop and the anticodon stem of the tRNA-like segment of the EGS. Methods are also disclosed to randomly select and to express a suitable EGS in vivo to make a selected RNA a target for cleavage by the host cell RNAase P, thus preventing expression of the function of the target RNA. The methods and compositions should be useful to prevent the expression of disease-causing genes in vivo.
Patent AU-775565-B2 (AU)
Title: Dry powder compositions having improved dispersivity
Inventor: LECHUGA-BALLESTEROS DAVID
IPC: A61P19/02
Filed: 2000-04-12
Granted: 2004-08-05
Abstract: The present invention provides a highly dispersible formulation comprising an active agent and a tripeptide comprising at least two leucyl residues. The composition of the invention possesses superior aerosol properties and is thus preferred for aerosolized administration to the lung. Also provided is a method for increasing the aerosol performance of an active-agent containing formulation for administration to the lung, which comprises the incorporation of a di- or tripeptide comprising at least two leucines into a formulation comprising an active agent.
Patent AU-577598-B2 (AU)
Title: Zinc bacitracin feed additive
Inventor: SCHMIDT MICHAEL
IPC: A23K50/30
Filed: 1985-06-20
Granted: 1988-09-29
Abstract: 1. Feed additive containing zinc bacitracin with improved stability under the action of heat and moisture and mechanical processing, characterised in that the feed additive is coated with a polymer.
Patent AU-777104-B2 (AU)
Title: Device for connecting and laying successive parts of a submarine pipeline from a boat and uses thereof
Inventor: ROGER PIERRE
IPC: F16L1/19
Filed: 2000-04-28
Granted: 2004-09-30
Abstract: A device for laying submarine pipeline from a vessel at sea. The device has a support or laying tower that can be inclined in a variable manner. The device has a workstation for assembling the successive parts of an offshore pipeline with the workstation attached to the vessel independently of the tower and is displaceable along the vessel to assemble the successive parts of the pipeline.
Patent AU-573906-B2 (AU)
Title: Cutting oil
Inventor: RAWLINSON ANTHONY PAUL
IPC: C10M173/00
Filed: 1985-10-08
Granted: 1988-06-23
Abstract: A composition for the preparation of a soluble-oil for use in a cutting fluid comprises a mineral oil and, as an emulsifier, an effective amount of a sulphonate of a branched polymer of a C<sub>3</sub> to C<sub>5</sub> olefin. Preferably the polyolefin chain of the sulphonate has an average molecular weight in the range 275 to 560 and the polyolefin is polyisobutene.A soluble-oil can be prepared from the above composition by the addition of a conventional corrosion inhibitor and diluted with water to make a cutting fluid. Advantages of the novel emulsifier are that they are resistant to breakdown by micro-organisms and do not require the addition of a coupling agent.
Patent AU-723408-B2 (AU)
Title: Oxygen concentrator
Inventor: MCCULLOH KEVIN GENE
IPC: B01D53/047
Filed: 1998-02-06
Granted: 2000-08-24
Abstract: An apparatus for providing oxygen-enriched air at a first pressure and at a second pressure, the second pressure being greater than the first pressure. The apparatus comprises, in combination, a pressure swing adsorption system (104) and a pressure intensifier (109). The pressure swing adsorption system (104) for enriching the oxygen content of air has a pressure of at least the first pressure. The pressure swing adsorption system (104) is adapted to provide oxygen-enriched air to a first outlet (106) at the first pressure and to provide oxygen-enriched air to a pressure intensifier (109) at the first pressure. The pressure intensifier (109) pressurizes the oxygen-enriched air and provides the oxygen-enriched air to a second outlet (112) at the second pressure. <IMAGE>
Patent AU-585962-B2 (AU)
Title: Polysilazane composition which can crosslink in the presence of a metal or a metal compound catalysing a hydrosilylation reaction
Inventor: LEBRUN JEAN-JACQUES
IPC: C08L83/16
Filed: 1986-03-27
Granted: 1989-06-29
Abstract: A crosslinkable composition comprising at least one polysilazane containing at least 2, preferably at least 3,  3BOND SiH groups per molecule and at least 2 SiR2 groups per molecule, R2 being an unsaturated hydrocarbon radical and a catalytically effective quantity of a metal element or of a metal compound to catalyze the hydrosilylation reaction SiH/SiR2. The compositions according to the invention can crosslink under the effect of heat and can be used for coating or impregnating substrates with ceramic material after pyrolysis. The mechanical properties of the crosslinked compositions are assessed by evaluating the relative rigidity RR measured by the fiber torsion pendulum method (FIG. 1).
Patent AU-769082-B2 (AU)
Title: Defined serumfree medical solution for ophthalmology
Inventor: SKELNIK DEBRA L
IPC: A01N1/02
Filed: 1999-10-28
Granted: 2004-01-15
Abstract: A defined serumfree medical solution for applications in Ophthalmology, that contains one or more cell nutrient supplements, and a growth factor(s) which maintains and enhances the preservation of eye tissues, including human corneal, retinal and corneal epithelial tissues at low to physiological temperatures (2 DEG C to 38 DEG C). This solution is composed of a defined aqueous nutrient and electrolyte solution, supplemented with a glycosaminoglycan(s),a deturgescent agent(s), an energy source(s), a buffer system(s),an antioxidant(s), membrane stabilizing agents, an antibiotic(s) and/or antimycotic agent(s), ATP or energy precursors, nutrient cell supplements, coenzymes and enzyme supplements, nucleotide precursors, hormonal supplements, non-essential amino acids, trace minerals, trace elements and a growth factor(s). <IMAGE>
Patent AU-581594-B2 (AU)
Title: Electric cooker heating unit
Inventor: SCHREDER FELIX
IPC: H05B3/68
Filed: 1986-05-23
Granted: 1989-02-23
Abstract: A heating unit for cooking points, baking oven muffles or the like is provided on the inside of its outer body (2), in the central zone (10), with two thermal cutouts (17, 18), which are preferably located in a common cutout casing (19) exclusively located in said central zone (10) and sense with their temperature sensors (24, 25) different regions of the heating surface or outer body (2). The differently set thermal cutouts (17, 18) and the heating resistors (7, 8, 9) separately connected into the leads ensure a differentiated disconnection of a more or less large part of the heating power, so that rerliable protection against overheating is ensured, in the case of a compact construction.
Patent AU-706815-B2 (AU)
Title: Magnetic separation method for iron carbide
Inventor: RUER JACQUES
IPC: C01B31/30
Filed: 1996-04-30
Granted: 1999-06-24
Abstract: PCT No. PCT/FR96/00658 Sec. 371 Date Jan. 20, 1998 Sec. 102(e) Date Jan. 20, 1998 PCT Filed Apr. 30, 1996 PCT Pub. No. WO96/34692 PCT Pub. Date Nov. 7, 1996A method for purifying iron carbide begins by feeding ore to a reaction chamber. A mixture of iron, iron oxides, gangue, and iron carbides is extracted from the reaction chamber. The temperature of the mixture is then adjusted to a range of 400 DEG -500 DEG  C. The mixture, at the adjusted temperature, is subjecting to a first magnetic field for separating the mixture into a magnetic fraction including iron and iron oxides from a non-magnetic fraction including gangue and iron carbides. This is followed by a cooling of the non-magnetic fraction of gangue and iron carbides below the Curie temperature of iron carbide. The gangue and iron carbides are subjecting to a second magnetic field for separating the iron carbides, that become magnetic, from the gangue that remains non-magnetic.
Patent AU-645256-B2 (AU)
Title: Antigenic epitopes present on membrane-bound but not secreted IgA
Inventor: CHANG TSE WEN
IPC: A61K39/395
Filed: 1990-06-21
Granted: 1994-01-13
Abstract: The invention relates to a method of using a peptide which has the sequence of epitopes which are present on B cell-bound but not secreted IgA. This induces production of the antibody itself. These extracellular peptide segments form, entirely or in part, antigenic epitopes unique to membrane-bound but not secreted IgA.
Patent AU-589427-B2 (AU)
Title: Pyridonecarboxylic acid derivatives and process for their preparation
Inventor: MASUZAWA KUNIYOSHI
IPC: C07D498/06
Filed: 1986-06-23
Granted: 1989-10-12
Abstract: Pyridonecarboxylic acid derivatives of the following formula.wherein R is hydrogen atom or lower alkyl group, R<sup>1</sup> is lower alkyl group, cycloalkyl group or haloalkyl group, Y is hydrogen atom or halogen atom, or Y and R<sup>1</sup> arewhich work together, R<sup>2</sup> is hydrogen atom, lower alkyl group, alkoxycarbonyl group or acyl group and n is 0 or 1; the hydrates and pharmaceutically acceptable salts thereof are useful as antibacterial agents.
Patent AU-629671-B2 (AU)
Title: Skin cream preparation for external use
Inventor: NAKAGAWA AKIRA
IPC: A61K47/00
Filed: 1990-07-27
Granted: 1992-10-08
Abstract: A water/oil skin cream for external use contains an active component together with a base consisting of (a) a diglycerol fatty acid ester and/or a sorbitan fatty acid ester with HLB 3 to 7 (1-10% wt.); (b) a polyvalent metal salt of a saturated or unsaturated fatty acid with 10-22C (0.01-1/0%); (c) a salt of an organic or inorganic acid (0.1-5%); (d) an oil phase component (such as squalane, isopropyl myristate, liquid paraffin or 2-octyldodecanol) (1-20%); and (e) water (70-90%). The active component is pref. an antiinflammatory, antibacterial or antiallergic, and forms 0.01-3% wt. of the total compsn.. Pref. the active component is 0.01-1% wt.. ketotifen or its fumarate salt.
Patent AU-727563-B2 (AU)
Title: Arrangement and method for producing expanded material
Inventor: STELZL THOMAS
IPC: B23K26/38
Filed: 1996-05-29
Granted: 2000-12-14
Abstract: In an arrangement for producing expanded material (8), in particular from foil-type webs (2) of metal, with a cutting device (3) for producing coherent strips of webs (5) of foil, and with an expanding device (6, 7) for expanding the web (5), the cutting device (3) comprises laser beam, water jet or electron beam (4)-emitting devices which are arranged substantially adjacent each other, transversely to the moving direction of the web (2), and which are controlled by a controlling device.
Patent AU-768961-B2 (AU)
Title: Pharmaceutically active plant preparation for the treatment of migraine
Inventor: SPIESS STEFAN
IPC: A61P25/06
Filed: 1999-09-22
Granted: 2004-01-08
Abstract: The invention relates to pharmaceutical combination preparations with synergistic action for the treatment of migraine. Said preparations contain plant-based components and/or preparations of Tanacetum parthenium in combination with Vitex agnus castus and/or Cimicifuga racemosa and/or Zingiber officinale as their pharmaceutically active ingredients. The combination preparation provided for in the invention is suitable for the treatment of not only the headache but also the other symptoms of migraine while avoiding the usual side-effects.
Patent AU-713246-B2 (AU)
Title: Methods of measuring the concentration of an analyte in a subject
Inventor: GROSS JOSEPH
IPC: G01N27/327
Filed: 1998-04-29
Granted: 1999-11-25
Abstract: A liquid delivery device comprising a housing having a lower surface for application to the skin of a subject and having a reservoir and a gas generation chamber therein separated by a displaceable membrane. Gas generated by an electrolytic cell under the control of a microprocessor causes the gas generation chamber to expand and the reservoir to contract, thereby discharging a liquid drug, such as insulin, from the reservoir via a hollow delivery needle extending from the lower surface. The delivery needle and a sensor needle both extend from the lower surface a sufficient distance so as to penetrate through the epidermis and into the dermis when the housing is pressed against the skin. The sensor needle has an enzymatic coating for the detection of an analyte, such as glucose in the subject's plasma. The delivery needle is made of platinum-iridium, and a current passes between the needles and a potentiostat circuit according to the amount of glucose detected. A reference electrode (silver/silver chloride) which rests against the subject's skin increases the accuracy of the glucose measurement. The current through the potentiostat circuit is measured by a voltmeter and a signal from the voltmeter is amplified and communicated to the microprocessor which determines the correct rate of delivery of the drug on the basis of the level of analyte detected in the subject's plasma.
Patent AU-740243-B2 (AU)
Title: Method of self-synchronization of configurable elements of a programmable component
Inventor: VORBACH MARTIN
IPC: G06F15/78
Filed: 1998-02-07
Granted: 2001-11-01
Abstract: A data processing system has a number of programmable modules that allow reconfiguration to be made and can be organised in two or three dimensional form. The modules are operated in a synchronised mode using signals that are generated with the data stream transmitted between the modules. The synchronising signals are transmitted to other elements over the bus together with addresses.
Patent AU-776465-B2 (AU)
Title: Stabilized antithrombin III preparation
Inventor: ROMISCH JURGEN
IPC: A61K47/02
Filed: 1999-12-07
Granted: 2004-09-09
Abstract: Antithrombin III preparation is claimed which is stabilized against pasteurization-induced loss of activity by the addition of saccharide(s) optionally in combination with arginine, lysine, histidine, phenylalanine, tryptophan, tyrosine, aspartic acid (or its salts) or glutamic acid (or its salts), where each of these aminoacids may also be admixed with glycine and/or glutamine. Antithrombin III preparation is claimed which is stabilized against pasteurization-induced loss of activity by the addition of saccharide(s) optionally in combination with arginine, lysine, histidine, phenylalanine, tryptophan, tyrosine, aspartic acid (or its salts) or glutamic acid (or its salts), where each of these aminoacids may also be admixed with glycine and/or glutamine. An Independent claim is included for a virus-inactivation treatment of the above antithrombin III preparation by heat treatment at 40-95 degrees C for 5-50 hours.
Patent AU-682864-B2 (AU)
Title: Process for production of human milk fat replacers
Inventor: QUINLAN PAUL THOMAS
IPC: C12P7/64
Filed: 1994-04-22
Granted: 1997-10-23
Abstract: PCT No. PCT/EP94/01304 Sec. 371 Date Nov. 7, 1995 Sec. 102(e) Date Nov. 7, 1995 PCT Filed Apr. 22, 1994 PCT Pub. No. WO94/26854 PCT Pub. Date Nov. 24, 1994Triglycerides with more than 40 wt % saturated fatty acids in the 2-position contain considerable amounts of trisaturated triglycerides; these trisaturated triglycerides are removed (reduced) by performing an enzymic conversion with a source providing unsaturated C18 to C22 residues, using a 1,3-specific enzyme.
Patent AU-626740-B2 (AU)
Title: Aminocarbonylcarbamates related to physostigmine, a process for their preparation and their use as medicaments
Inventor: GLAMKOWSKI EDWARD JOSEPH
IPC: A61K31/40
Filed: 1990-11-29
Granted: 1992-08-06
Abstract: The present invention relates to various derivatives related to physostigmine of the formula I <CHEM>     where    Z is hydrogen, halogen or loweralkyl;  R1 is loweralkyl, cycloalkyl or aryl; and  R2 is loweralkyl or cycloalkyl;   the 3aS-cis isomer or the 3aR-isomer thereof or a mixture of the two isomers including the racemic mixture, or a pharmaceutically acceptable acid addition salt thereof, and a process for their preparation. The compounds according to the invention are useful for enhancing cholinergic function, and as analgesic agents.
Patent AU-635471-B2 (AU)
Title: Multiple layer die head with adjustable gaps
IPC: B29C48/325
Filed: 1990-12-11
Granted: 1993-03-18
Abstract: An extrusion die head (10) for producing multiple layer tubular plastic bodies is disclosed in which the size of the tubular resin flow passage for at least one of the resin layers is infinitely adjustable at the point where two or more resin layers merge together to form a multiple layer stream. The adjustable passages are formed by two spaced inclined surfaces at the downstream end of the passages. The thickness of the passages is varied by axially moving one surface relative to the other. The moveable inclined surface (60) is carried on an annular ring member (62) mounted in the die head (10). In one embodiment, the ring (62) is replaceable with another ring member to axially move the surface, thereby adjusting the layer thickness. In another embodiment, the ring member (62) is threadably mounted in the die head so that rotation of the ring causes axial movement of the surface to adjust layer thickness. In the preferred embodiment the ring member is rotated by a drive mechanism operable from outside the die head for adjustment without disassembly of the die head. Adjustability of the gap sizes in the die head widens the range the relative thicknesses of the layers and widens the range of relative viscosity values that can be used. The versatility and usefulness of the die head is thus increased over that of die heads employing fixed gaps. <IMAGE>